Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol
- 24 September 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 322 (3), 923-929
- https://doi.org/10.1016/j.bbrc.2004.07.204
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agentCurrent Opinion in Oncology, 2003
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003
- 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIFCancer Cell, 2003
- HIF hydroxylation and the mammalian oxygen-sensing pathwayJCI Insight, 2003
- Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expressionThe FASEB Journal, 2002
- A Conserved Family of Prolyl-4-Hydroxylases That Modify HIFScience, 2001
- C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl HydroxylationCell, 2001
- Superoxide dismutase as a target for the selective killing of cancer cellsNature, 2000
- 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug CandidateCancer and Metastasis Reviews, 2000
- Expression of hypoxia-inducible factor 1: mechanisms and consequencesBiochemical Pharmacology, 1999